A23V2250/06

Flavor Modifiers For Meat Analog Products

A flavor modifier composition for a meat analog is provided. The flavor modifier composition includes a yeast extract; a fatty acid; peptide material having a molecular weight of from about 300 to about 10,000 daltons; and at least two free amino acids wherein at least one free amino acid is a sulfur containing amino acid.

NUTRITIONAL COMPOSITION
20230113424 · 2023-04-13 ·

The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.

NUTRITIONAL COMPOSITION
20230113424 · 2023-04-13 ·

The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.

Nutritional compositions containing milk-derived peptides and uses thereof

Provided are nutritional compositions having a protein component that includes certain peptides and/or bioactive peptides. Further disclosed are nutritional composition having a protein source that includes intact protein, beta-casein enriched casein hydrolysate, and/or peptides weighing from about 500 Da to about 1,999 Da. The nutritional compositions disclosed are suitable for administration to pediatric subjects, such as infants.

Composition with high free amino acid contents and use as a starting material and complete feed for animal feed
11678680 · 2023-06-20 · ·

A keratin hydrolysate including at least 94% by weight of free amino acids relative to the total weight of the amino acids of the hydrolysate. The keratin hydrolysate includes at least 93% of free valine relative to the total weight of valine in the hydrolysate, at least 90% free isoleucine relative to the total weight of isoleucine in the hydrolysate, and at least 95% of free leucine relative to the total weight of leucine in the hydrolysate. A method for producing the keratin hydrolysate, a composition comprising the hydrolysate and an animal feed containing the hydrolysate are also disclosed.

Composition with high free amino acid contents and use as a starting material and complete feed for animal feed
11678680 · 2023-06-20 · ·

A keratin hydrolysate including at least 94% by weight of free amino acids relative to the total weight of the amino acids of the hydrolysate. The keratin hydrolysate includes at least 93% of free valine relative to the total weight of valine in the hydrolysate, at least 90% free isoleucine relative to the total weight of isoleucine in the hydrolysate, and at least 95% of free leucine relative to the total weight of leucine in the hydrolysate. A method for producing the keratin hydrolysate, a composition comprising the hydrolysate and an animal feed containing the hydrolysate are also disclosed.

Nutritional composition
11253561 · 2022-02-22 ·

The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.

Nutritional composition
11253561 · 2022-02-22 ·

The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. Methods are provided that utilize specific combinations of selected forms selenium. chromium, and molybdenum in combination with fish oil.

2-AMINOETHANOL DIHYDROGEN PHOSPHATE-BASED DIETARY SUPPLEMENT AND SYNTHESIS PROCESS THEREOF
20170296560 · 2017-10-19 · ·

This invention discloses a process for creating an amino acid-based vitamin and mineral dietary supplement and muscle builder having therapeutic activities such as an antioxidant and a metabolic regulator, a regulator of possible cell dysfunctions, an adjuvant of human vitality and well-being and reduction of pain caused by different diseases wherein 2-aminoetanol dihydrogen phosphate is synthesized from phosphorus pentoxide and/or phosphoric acid and/or orthophosphoric acid reacted as monoethanolamine and/or diethanolamine and/or triethanolamine. These are reacted under optimal temperature conditions (−10 to +35° C.) at the specific molar ratios for each reagent used.

2-AMINOETHANOL DIHYDROGEN PHOSPHATE-BASED DIETARY SUPPLEMENT AND SYNTHESIS PROCESS THEREOF
20170296560 · 2017-10-19 · ·

This invention discloses a process for creating an amino acid-based vitamin and mineral dietary supplement and muscle builder having therapeutic activities such as an antioxidant and a metabolic regulator, a regulator of possible cell dysfunctions, an adjuvant of human vitality and well-being and reduction of pain caused by different diseases wherein 2-aminoetanol dihydrogen phosphate is synthesized from phosphorus pentoxide and/or phosphoric acid and/or orthophosphoric acid reacted as monoethanolamine and/or diethanolamine and/or triethanolamine. These are reacted under optimal temperature conditions (−10 to +35° C.) at the specific molar ratios for each reagent used.